Company intelligence / Profile preview

Zennova

Monmouth Junction, New Jersey, United Stateszennova.com ↗

Ownership: Private
Employees: ~100
Development stage: Other

Overview

Zennova is a specialty pharmaceutical company dedicated to developing and commercializing innovative medicines through advanced drug delivery technologies. The company focuses on the 505(b)(2) regulatory pathway to create value-added products with improved clinical benefits, such as enhanced bioavailability and reduced side effects. Their core technology platforms include Z-Sorb for oral delivery, Z-Gel for topical applications, and proprietary microneedle systems for transdermal delivery. With operations in the United States and China, Zennova integrates R&D, clinical development, and GMP manufacturing to address unmet needs in pain management, ophthalmology, and CNS disorders.

Therapeutic areas: OphthalmologyPsychiatryNeurologyDermatology
Modalities: Small moleculeMicroneedleLong-acting injectableTopical
Industry: Biotech

Beyond the preview

Go deeper on Zennova.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zennova.